A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project.
Homocysteine (Hcy) plasma level is an independent risk marker for venous thrombosis, myocardial infarction, stroke, congestive heart failure, osteoporotic fractures, and Alzheimer disease. Hcy levels are determined by the interaction of genetic and environmental factors. The genetic basis is still poorly understood, since only the MTHFR 677 C-->T polymorphism has been consistently associated with plasma Hcy levels. We conducted a genomewide linkage scan for genes affecting variation in plasma Hcy levels in 398 subjects from 21 extended Spanish families. A variance-components linkage method was used to analyze the data. The strongest linkage signal (LOD score of 3.01; genomewide P = .035) was found on chromosome 11q23, near marker D11S908, where a candidate gene involved in the metabolism of Hcy (the nicotinamide N-methyltransferase gene [NNMT]) is mapped. Haplotype analyses of 10 single-nucleotide polymorphisms within this gene found one haplotype associated with plasma Hcy levels (P = .0003). Our results, to our knowledge, represent the first genomic scan for quantitative variation in Hcy plasma levels. They strongly suggest that the NNMT gene could be a major genetic determinant of plasma Hcy levels in Spanish families. Since this gene encodes an enzyme involved in Hcy synthesis, this finding would be consistent with known biochemical pathways. These data could be relevant in determining the relationships between Hcy level, cardiovascular disease, osteoporosis, and Alzheimer disease.
Souto
Juan Carlos
JC
Unitat de Trombosi i Hemostàsia, Departament d' Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. jsouto@hsp.santpau.es
Blanco-Vaca
Francisco
F
Soria
José Manuel
JM
Buil
Alfonso
A
Almasy
Laura
L
Ordoñez-Llanos
Jordi
J
Martín-Campos
Jesús Ma
JM
Lathrop
Mark
M
Stone
William
W
Blangero
John
J
Fontcuberta
Jordi
J
D002874:Chromosome Mapping; D002880:Chromosomes, Human, Pair 11; D015971:Gene Expression Regulation, Enzymologic; D008040:Genetic Linkage; D005819:Genetic Markers / Q000235:genetics; D014644:Genetic Variation; D015894:Genome, Human; D006239:Haplotypes; D006579:Heterozygote; D006710:Homocysteine / Q000097:blood* / Q000235:genetics*; D006801:Humans; D008126:Lod Score; D008780:Methyltransferases / Q000235:genetics; D008954:Models, Biological; D050903:Nicotinamide N-Methyltransferase; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D013030:Spain; D019851:Thrombophilia / Q000097:blood / Q000235:genetics*
D005819:Genetic Markers; D006710:Homocysteine; D008780:Methyltransferases; C494406:NNMT protein, human; D050903:Nicotinamide N-Methyltransferase